The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Microvascular basement membranes in diabetes mellitus
Abstract
The alterations in the microvascular system of diabetes mellitus patients are responsible for the most devastating complications of this widespread disease. In the kidney, the microangiopathy leads to thickening of the glomerular capillary basement membrane but also to the expansion of the mesangial matrix and thickening of the tubular basement membrane. Several mechanisms are implicated in the pathogenesis of diabetic renal microangiopathy. These include increased synthesis of type IV collagen following hyperglycaemia‐induced alteration of the pattern of podocyte–integrin expression, decreased expression of matrix metalloproteinases (MMP‐2 and 3), and increased expression of tissue inhibitor of metalloproteinase (TIMP). An altered morphology of podocytes accompanies these basement membrane alterations. Other factors which may contribute to renal matrix accumulation include vascular endothelial growth factor (VEGF), since treatment with anti‐VEGF antibodies attenuates glomerular basement membrane thickening, platelet‐derived growth factor (PDGF) (B chain) and its receptor, which appear to be highly expressed in mesangial and visceral epithelial cells and might play a role in the development of diabetic nephropathy. Also oxygen radicals/oxidative stress may play a role in matrix accumulation in diabetic nephropathy as aminoguanidine, an inhibitor of the formation of advanced glycation end‐products but with antioxidant properties, attenuates diabetic nephropathy. Retinal diabetic microangiopathy follows much the same principles, be it that microvascular proliferation is a distinctive element in the retina. Nephropathy and retinopathy occur frequently but not always together, indicating that in their multifactorial pathogenesis much remains to be clarified. Copyright © 2003 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C., & Mauer, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390202 · Cited by 1,135
Diabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 697
Pericytes and the Pathogenesis of Diabetic Retinopathy
Hammes, H.-P., Lin, J., Renner, O., Shani, M., Lundqvist, A., Betsholtz, C., Brownlee, M., & Deutsch, U. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3107 · Cited by 665
Sharma, K., Jin, Y., Guo, J., & Ziyadeh, F. N. (1996) · Diabetes · doi:10.2337/diab.45.4.522 · Cited by 662
The missing link: A single unifying mechanism for diabetic complications
Nishikawa, T., Edelstein, D., & Brownlee, M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07705.x · Cited by 510
TANJI, N., MARKOWITZ, G. S., FU, C., KISLINGER, T., TAGUCHI, A., PISCHETSRIEDER, M., STERN, D., SCHMIDT, A. M., & D'AGATI, V. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191656 · Cited by 487
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
Caramori, M. L., Fioretto, P., & Mauer, M. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1399 · Cited by 434
Oxidative Stress and Programmed Cell Death in Diabetic Neuropathy
VINCENT, A. M., BROWNLEE, M., & RUSSELL, J. W. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02108.x · Cited by 361
Podocyte Number in Normotensive Type 1 Diabetic Patients With Albuminuria
White, K. E., Bilous, R. W., Marshall, S. M., El Nahas, M., Remuzzi, G., Piras, G., De Cosmo, S., Viberti, G., & (ESPRIT), O. B. O. T. E. S. F. T. P. O. R. D. I. T. 1. D. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3083 · Cited by 315
Flyvbjerg, A., Dagnæs-Hansen, F., De Vriese, A. S., Schrijvers, B. F., Tilton, R. G., & Rasch, R. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3090 · Cited by 309
THE CELLULAR AND MOLECULAR MECHANISMS OF DIABETIC COMPLICATIONS
King, G. L., & Brownlee, M. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70324-8 · Cited by 290
Ishii, H., Koya, D., & King, G. L. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050187 · Cited by 274
Giardino, I., Fard, A. K., Hatchell, D. L., & Brownlee, M. (1998) · Diabetes · doi:10.2337/diabetes.47.7.1114 · Cited by 258
Pathogenesis of diabetic nephropathy
Raptis, A., & Viberti, G. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-18600 · Cited by 256
High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures
Ayo, S. H., Radnik, R., Garoni, J. A., Troyer, D. A., & Kreisberg, J. I. (1991) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1991.261.4.f571 · Cited by 255
Cai, W., Gao, Q.-D., Zhu, L., Peppa, M., He, C., & Vlassara, H. (2002) · Molecular Medicine · doi:10.1007/bf03402014 · Cited by 235
Hammes, H. P., Lin, J., Bretzel, R. G., Brownlee, M., & Breier, G. (1998) · Diabetes · doi:10.2337/diabetes.47.3.401 · Cited by 222
Differential accumulation of advanced glycation end products in the course of diabetic retinopathy
Hammes, H.-P., Alt, A., Niwa, T., Clausen, J. T., Bretzel, R. G., Brownlee, M., & Schleicher, E. D. (1999) · Diabetologia · doi:10.1007/s001250051221 · Cited by 205
Glomerular heparan sulfate alterations: Mechanisms and relevance for proteinuria
Raats, C. J. I., Van Den Born, J., & Berden, J. H. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00858.x · Cited by 200
The Incidence of Retinopathy 10 Years After Diagnosis in Young Adult People With Diabetes
Henricsson, M., Nyström, L., Blohmé, G., Östman, J., Kullberg, C., Svensson, M., Schölin, A., Arnqvist, H. J., Björk, E., Bolinder, J., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.349 · Cited by 191
Sugiura, T., & Berditchevski, F. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.6.1375 · Cited by 184
Wang, X., Shaw, S., Amiri, F., Eaton, D. C., & Marrero, M. B. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3505 · Cited by 176
Cosgrove, D., Rodgers, K., Meehan, D., Miller, C., Bovard, K., Gilroy, A., Gardner, H., Kotelianski, V., Gotwals, P., Amatucci, A., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64802-x · Cited by 176
Isono, M., Chen, S., Won Hong, S., Carmen Iglesias-de la Cruz, M., & Ziyadeh, F. N. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02084-3 · Cited by 173
Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility
Mott, J. D., Khalifah, R. G., Nagase, H., Shield, C. F., Hudson, J. K., & Hudson, B. G. (1997) · Kidney International · doi:10.1038/ki.1997.455 · Cited by 170
Structural involvement in type 1 and type 2 diabetic nephropathy.
Vestra, M. D., Saller, A., Bortoloso, E., Mauer, M. S., & Fioretto, P. (2000) · PubMed · Cited by 160
Basement membrane abnormalities in human eyes with diabetic retinopathy.
Ljubimov, A. V., Burgeson, R. E., Butkowski, R. J., Couchman, J. R., Zardi, L., Ninomiya, Y., Sado, Y., Huang, Z. S., Nesburn, A. B., & Kenney, M. C. (1996) · Journal of Histochemistry & Cytochemistry · doi:10.1177/44.12.8985139 · Cited by 160
Activation of Tubular Epithelial Cells in Diabetic Nephropathy
Morcos, M., Sayed, A. A. R., Bierhaus, A., Yard, B. A., Waldherr, R., Merz, W. E., Klöting, I., Schleicher, E. D., Mentz, S., Baki, R. A. E., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3532 · Cited by 158
Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury.
Phillips, A. O., & Steadman, R. (2002) · PubMed · doi:10.14670/hh-17.247 · Cited by 146
Zeisberg, M., Maeshima, Y., Mosterman, B., & Kalluri, R. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61150-9 · Cited by 142
Park, C. W., Kim, J., Lee, J. W., Kim, Y. S., Ahn, H. J., Shin, Y. S., Kim, S.-Y., Choi, E. J., Chang, Y. S., & Bang, B. K. (2000) · Diabetologia · doi:10.1007/s001250051567 · Cited by 138
Hofmann, U. B., Westphal, J. R., van Kraats, A. A., Ruiter, D. J., & van Muijen, G. N. P. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000701)87:1<12::aid-ijc3>3.0.co;2-a · Cited by 132
Reversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in db/db mice
Chen, S., de la Cruz, M. D. C. I., Jim, B., Hong, S. W., Isono, M., & Ziyadeh, F. N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02708-0 · Cited by 126
Mechanisms of Progressive Renal Disease in Glomerulonephritis
Couser, W. G., & Johnson, R. J. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80971-1 · Cited by 121
Anti-Glycated Albumin Therapy Ameliorates Early Retinal Microvascular Pathology in db/db Mice
Clements, R. S., Robison, W. G., & Cohen, M. P. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00051-2 · Cited by 109
Relationship Between Retinal and Glomerular Lesions in IDDM Patients
Chavers, B. M., Mauer, S. M., Ramsay, R. C., & Steffes, M. W. (1994) · Diabetes · doi:10.2337/diab.43.3.441 · Cited by 107
Altering expression of α3β1 integrin on podocytes of human and rats with diabetes
Chen, H.-C., Chen, C., Guh, J., Chang, J., Shin, S.-J., & Lai, Y. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00815-8 · Cited by 106
Hammes, H. P., Weiss, A., Hess, S., Araki, N., Horiuchi, S., Brownlee, M., & Preissner, K. T. (1996) · PubMed · Cited by 104
Vascular Endothelial Growth Factor Receptors in Human Mesangium in Vitro and in Glomerular Disease
Thomas, S., VANUYSTEL, J., Gruden, G., RODRÍGUEZ, V., Burt, D. J., Gnudi, L., HARTLEY, B., & Viberti, G. C. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1171236 · Cited by 102
Evans, T., Deng, D. X., Chen, S., & Chakrabarti, S. (2000) · Diabetes · doi:10.2337/diabetes.49.4.662 · Cited by 101
Kitsiou, P. V., Tzinia, A. K., Stetler‐Stevenson, W. G., Michael, A. F., Fan, W.-W., Zhou, B., & Tsilibary, E. C. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00266.2002 · Cited by 94
Self-citationBasement membrane and growth factor gene expression in normal and diabetic human retinas
Spirin, K. S., Saghizadeh, M., Lewin, S. L., Zardi, L., Kenney, M. C., & Ljubimov, A. V. (1999) · Current Eye Research · doi:10.1076/ceyr.18.6.490.5267 · Cited by 90
Glomerular epithelial foot processes and filtration slits in IDDM patients
Bj�rn, S. F., Bangstad, H. ‐., Hanssen, K. F., Nyberg, G., Walker, J. D., Viberti, G. C., & �sterby, R. (1995) · Diabetologia · doi:10.1007/bf00422369 · Cited by 86
Regoli, M., & Bendayan, M. (1997) · Diabetologia · doi:10.1007/s001250050637 · Cited by 85
Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
Vestra, M. D., Saller, A., Mauer, M. S., & Fioretto, P. (2001) · PubMed · Cited by 84
Regulation of fibronectin matrix deposition and cell proliferation by the PINCH‐ILK‐CH‐ILKBP complex
Guo, L., & Wu, C. (2002) · The FASEB Journal · doi:10.1096/fj.02-0089fje · Cited by 84
Reddy, M. A., Adler, S. G., Kim, Y.-S., Lanting, L. L., Rossi, J. J., Kang, S., Nadler, J. L., SHAHED, A. R., & Natarajan, R. D. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00181.2002 · Cited by 83
Suzuma, I., Suzuma, K., Ueki, K., Hata, Y., Feener, E. P., King, G. L., & Aiello, L. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105336200 · Cited by 79
Chronic diabetic nephropathy: role of inducible nitric oxide synthase
Trachtman, H., Futterweit, S., Pine-Twaddell, E. D., Mann, J. F., & Valderrama, E. (2002) · Pediatric Nephrology · doi:10.1007/s004670200004 · Cited by 77
Signaling pathways and late‐onset gene induction associated with renal mesangial cell hypertrophy
Goruppi, S., Bonventre, J. V., & Kyriakis, J. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf535 · Cited by 75
Modulation of matrix metalloprotease-2 and invasion in human glioma cells by α3β1 integrin
Chintala, S. K., Sawaya, R. A., Gokaslan, Z. L., & Rao, J. S. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04215-2 · Cited by 74
Cohen, M. P., Lautenslager, G. T., & Shearman, C. W. (2001) · Metabolism · doi:10.1053/meta.2001.28074 · Cited by 73
DiPersio, C. M., Shao, M., Costanzo, L. D., Kreidberg, J. A., & Hynes, R. O. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.16.2909 · Cited by 73
Mamputu, J., & Renier, G. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00229-x · Cited by 68
Krishnamurti, U., Rondeau, É., Sraer, J., Michael, A. F., & Tsilibary, E. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27966 · Cited by 63
Self-citationSorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes
Amano, S., Yamagishi, S., Kato, N., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02584-6 · Cited by 57
Altered proliferation of retinal microvascular cells on glycated matrix.
Kalfa, T. A., Gerritsen, M. E., Carlson, E. C., Binstock, A. J., & Tsilibary, E. C. (1995) · PubMed · Cited by 50
Self-citationBeltramo, E., Pomero, F., Allione, A., et al. (2002) · Diabetologia · doi:10.1007/s00125-001-0761-x · Cited by 50
Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture.
Castellon, R., Caballero, S., Hamdi, H., Atilano, S. R., Aoki, A. M., Tarnuzzer, R. W., Kenney, M. C., Grant, M. B., & Ljubimov, A. V. (2002) · PubMed · Cited by 48
Nakagawa, H., Sasahara, M., Haneda, M., Koya, D., Hazama, F., & Kikkawa, R. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00144-8 · Cited by 46
Yard, B. A., Kahlert, S., Engelleiter, R., Resch, S., Waldherr, R., Groffen, A. J. A., van den Heuvel, L. P., Born, J. V. D. W., Berden, J. H. M., Kröger, S., et al. (2001) · Nephron Experimental Nephrology · doi:10.1159/000052614 · Cited by 44
Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain
Nishikawa, T., Giardino, I., Edelstein, D., & Brownlee, M. (2000) · Current Eye Research · doi:10.1076/0271-3683(200007)2111-zft581 · Cited by 43
Morphological Changes in the Rat Kidney Following Long-Term Diabetes
Obineche, E. N., Mensah‐Brown, E. P. K., Chandranath, S. I., Ahmed, I., Naseer, O., & Adem, A. (2001) · Archives of Physiology and Biochemistry · doi:10.1076/apab.109.3.241.11592 · Cited by 38
Chavakis, E., Riecke, B., Lin, J., Linn, T., Bretzel, R. G., Preissner, K. T., Brownlee, M., & Hammes, H. (2002) · Diabetologia · doi:10.1007/s00125-001-0727-z · Cited by 37
Xu, X., Li, Z., Luo, D., Huang, Y., Zhu, J., Wang, X., Hu, H., & Patrick, C. (2003) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-002-0575-7 · Cited by 37
Effect of Matrix Glycation on Expression of Type IV Collagen, MMP-2, MMP-9 and TIMP-1 by Human
Anderson, S. S., Wu, K., Nagase, H., Stetler‐Stevenson, W. G., Kim, Y., & Tsilibary, E. C. (1996) · Cell Communication & Adhesion · doi:10.3109/15419069609010765 · Cited by 36
Self-citationKrishnamurti, U., Chen, Y., Michael, A., Kim, Y., Fan, W. W., Wieslander, J., Brunmark, C., Rondeau, É., Sraer, J., Delarue, F., et al. (1996) · PubMed · Cited by 34
Self-citationMonciotti, C., Semplicini, A., Morocutti, A., Maioli, M., Cipollina, M. R., Barzon, I., Palaro, C., Brocco, E., Trevisan, M., Fioretto, P., et al. (1997) · Diabetologia · doi:10.1007/s001250050730 · Cited by 33
van der Pijl, J. W., Daha, M. R., van den Born, J., Verhagen, N. A. M., Lemkes, H. H. P. J., Bucala, R., Berden, J. H. M., Zwinderman, A. H., Bruijn, J. A., van Es, L. A., et al. (1998) · Diabetologia · doi:10.1007/s001250050989 · Cited by 31
Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity
Trevisan, R., Fioretto, P., Barbosa, J. J., & Mauer, M. S. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00478.x · Cited by 31
Ikehara, K., Tada, H., Kuboki, K., & Inokuchi, T. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00194-8 · Cited by 23
Glucose-Induced Alteration of Integrin Expression and Function in Cultured Human Mesangial Cells
Setty, S., Anderson, S. S., Wayner, E. A., Kim, Y., Clegg, D., & Tsilibary, E. C. (1995) · Cell Communication & Adhesion · doi:10.3109/15419069509081286 · Cited by 22
Self-citationSodium-hydrogen antiporter: its possible role in the genesis of diabetic nephropathy
Trevisan, R., & Viberti, G. C. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.4.643 · Cited by 21
Gambaro, G., D’Angelo, A., Prete, D. D., Ceol, M., Garbisa, S., Bertaglia, G., Forino, M., Baggio, B., & Anglani, F. (1999) · American Journal of Nephrology · doi:10.1159/000013495 · Cited by 17
Cited by
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Diabetes and Kidney Disease: Role of Oxidative Stress
Jha, J. C., Banal, C., Chow, B. S. M., Cooper, M. E., & Jandeleit-Dahm, K. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6664 · Cited by 660
From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease
Wolf, G., Chen, S., & Ziyadeh, F. N. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1626 · Cited by 565
Wolf, G. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01429.x · Cited by 360
Pericyte Loss in Diabetic Retinopathy: Mechanisms and Consequences
Beltramo, E., & Porta, M. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990022 · Cited by 317
Metadata
- Authors
- Tsilibary, E. C.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2003-07
- Volume
- 200
- Issue
- 4
- Pages
- 537-546
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2048393160
- Cited by
- 267
- References
- 74
- FWCI
- 10.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.